 |
Iodine (131I) murine IgG1 monoclonal antibody against CD276 |
|---|---|
| Trade Name | |
| Orphan Indication | Neuroblastoma |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Y-mAbs Therapeutics A/S |
Related Access Program
South Plains Oncology Consortium – Recurrent Neuroblastoma
Catalyst Pharmaceuticals, Inc. – Downbeat Nystagmus
South Plains Oncology Consortium – Neuroblastoma
British Columbia Cancer Agency – Neuroblastoma
South Plains Oncology Consortium – Neuroblastoma
Children’s Hospital of Philadelphia – Neuroblastoma
University of California, San Francisco – Neuroblastoma
Jubilant DraxImage Inc. – Neuroblastoma
Children’s Hospital Medical Center, Cincinnati – Neuroblastoma
Apeiron Biologics AG – Neuroblastoma